Rate Professor Janette Vardy

Professional Summary: Professor Janette Vardy

Professor Janette Vardy is a distinguished medical oncologist and academic at the University of Sydney, Australia. With a focus on improving patient outcomes through innovative research, she has made significant contributions to the field of oncology, particularly in the areas of cancer survivorship and cognitive impairment related to cancer treatments.

Academic Background and Degrees

Professor Vardy holds the following qualifications:

• MBBS (Bachelor of Medicine, Bachelor of Surgery) - University of Newcastle, Australia
• PhD in Medicine - University of Sydney, Australia
• Fellow of the Royal Australasian College of Physicians (FRACP)

Research Specializations and Academic Interests

Professor Vardy's research primarily focuses on:

• Cancer survivorship and quality of life post-treatment
• Cognitive impairment ('chemobrain') in cancer patients
• Supportive care in oncology
• Long-term effects of cancer therapies

Career History and Appointments

Professor Vardy has held several key positions in academia and clinical practice:

• Professor of Cancer Medicine, University of Sydney, Sydney, Australia
• Medical Oncologist, Concord Repatriation General Hospital, Sydney
• Director, Sydney Cancer Survivorship Centre, Concord Hospital
• Research Lead, Cancer Survivorship Program, University of Sydney

Major Awards, Fellowships, and Honors

Professor Vardy has been recognized for her contributions to oncology and survivorship research:

• Recipient of multiple research grants from the National Health and Medical Research Council (NHMRC), Australia
• Awarded funding from Cancer Australia for survivorship studies

Key Publications

Professor Vardy has authored numerous impactful publications in high-ranking journals. A selection of her key works includes:

• Vardy, J., & Tannock, I. F. (2007). 'Cognitive function after chemotherapy in adults with solid tumours.' Critical Reviews in Oncology/Hematology.
• Vardy, J., et al. (2015). 'Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: A prospective, longitudinal, controlled study.' Journal of Clinical Oncology.
• Vardy, J., et al. (2019). 'Mechanisms of chemotherapy-induced cognitive impairment: A review of animal and human studies.' Neuroscience & Biobehavioral Reviews.

Influence and Impact on Academic Field

Professor Vardy is a leading figure in cancer survivorship research, particularly in understanding and addressing cognitive impairment associated with cancer treatments, often referred to as 'chemobrain.' Her work has influenced clinical guidelines and supportive care practices, improving the quality of life for cancer survivors worldwide. Her research has been instrumental in advocating for multidisciplinary approaches to cancer care, bridging oncology, psychology, and neuroscience.

Public Lectures, Committees, and Editorial Contributions

Professor Vardy is actively involved in the academic and clinical community:

• Regular speaker at international conferences on cancer survivorship and supportive care
• Member of various committees focused on cancer care and survivorship, including roles with Cancer Australia
• Editorial board member and reviewer for prominent oncology journals